A detailed history of Handelsbanken Fonder Ab transactions in Organon & Co. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 68,250 shares of OGN stock, worth $1.02 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,250
Previous 64,000 6.64%
Holding current value
$1.02 Million
Previous $1.33 Million 1.43%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$18.65 - $23.03 $79,262 - $97,877
4,250 Added 6.64%
68,250 $1.31 Million
Q2 2024

Aug 05, 2024

SELL
$17.45 - $21.96 $36,645 - $46,116
-2,100 Reduced 3.18%
64,000 $1.33 Million
Q1 2024

May 13, 2024

BUY
$13.78 - $18.8 $279,734 - $381,640
20,300 Added 44.32%
66,100 $1.24 Million
Q4 2023

Feb 01, 2024

BUY
$10.95 - $17.32 $52,560 - $83,136
4,800 Added 11.71%
45,800 $660,000
Q1 2023

Apr 28, 2023

BUY
$21.42 - $32.08 $434,826 - $651,224
20,300 Added 98.07%
41,000 $964,000
Q4 2022

Feb 07, 2023

SELL
$23.31 - $28.61 $1.15 Million - $1.41 Million
-49,446 Reduced 70.49%
20,700 $578,000
Q3 2022

Oct 27, 2022

BUY
$23.4 - $34.25 $62,407 - $91,344
2,667 Added 3.95%
70,146 $1.64 Million
Q2 2022

Aug 03, 2022

BUY
$31.66 - $38.9 $312,357 - $383,787
9,866 Added 17.12%
67,479 $2.28 Million
Q1 2022

May 11, 2022

SELL
$30.45 - $39.36 $40,955 - $52,939
-1,345 Reduced 2.28%
57,613 $2.01 Million
Q4 2021

Feb 08, 2022

SELL
$28.67 - $37.13 $60,321 - $78,121
-2,104 Reduced 3.45%
58,958 $1.8 Million
Q3 2021

Nov 10, 2021

SELL
$28.63 - $35.64 $99,260 - $123,563
-3,467 Reduced 5.37%
61,062 $2 Million
Q2 2021

Aug 03, 2021

BUY
$28.45 - $38.0 $1.84 Million - $2.45 Million
64,529 New
64,529 $1.95 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Handelsbanken Fonder Ab Portfolio

Follow Handelsbanken Fonder Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.